Key result
Balloon-expandable valves offer no independent long-term survival advantage over self-expanding valves.
Why the study?
Female patients with aortic stenosis frequently present with a small aortic annulus, but evidence comparing long-term outcomes of balloon-expandable valves versus self-expanding valves in this context is limited.
Does transcatheter aortic valve replacement using balloon-expandable valves compared to self-expanding valves improve 7-year clinical outcomes in female patients with aortic stenosis?
Cohort (n=2,632)
Does transcatheter aortic valve replacement using balloon-expandable valves compared to self-expanding valves improve 7-year clinical outcomes in female patients with aortic stenosis?
Absolute Event Rate: 51.5% vs 57.4%
p-value: p=0.021
Although balloon-expandable valves showed lower 7-year mortality and stroke rates compared to self-expanding valves in propensity-matched women undergoing TAVR, valve type was not an independent predictor of long-term outcomes after multivariable adjustment.
BACKGROUND: Female patients with aortic stenosis frequently present with a small aortic annulus (SAA), which may result in unfavorable echocardiographic cardiac function after transcatheter aortic valve replacement. However, evidence comparing the long-term outcomes of balloon-expandable valves (BEVs) and self-expanding valves (SEVs) in this context is limited. OBJECTIVES: This study compares the 7-year clinical outcomes after transcatheter aortic valve replacement using BEV and SEV in female patients. METHODS: Overall, 1,827 female patients treated with BEV and 805 treated with SEV were identified from the Optimized transCathEter vAlvular intervention-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry. One-to-one propensity score matching (PSM) was performed to adjust for confounding factors, resulting in 744 matched patients per group. The primary clinical endpoints included all-cause mortality, stroke, and heart failure rehospitalization. RESULTS: Overall, 1,303 patients (87.6%) had a SAA. Echocardiographic assessments indicated that BEV had smaller effective orifice area and higher mean pressure gradient than did SEV throughout the follow-up period. In the PSM analysis, BEV was associated with lower all-cause mortality (51.5% vs 57.4%; log-rank, P = 0.021) and stroke at 7 years (10.8% vs 16.7%; Fine-Gray, P = 0.008). Heart failure rehospitalization rates were similar between groups. In multivariable analyses, valve type was not independently associated with long-term outcomes, and subgroup analyses considering annulus size yielded consistent results. CONCLUSIONS: For women predominantly presenting with a SAA, BEV demonstrated decreased echocardiac performance compared with SEV. Although PSM analysis indicated more favorable outcomes with BEV, valve type was not independently associated with long-term prognosis after multivariable adjustment. These findings suggest that both types of transcatheter heart valves may be an acceptable option in this patient population.
No takes yet. Share an insight, caveat, or question.
Iwata et al. (2026) conducted a cohort in Aortic stenosis (n=2,632). Balloon-expandable valves vs. Self-expanding valves was evaluated on All-cause mortality (p=0.021). Balloon-expandable valves had lower 7-year mortality than self-expanding valves (51.5% vs 57.4%; P=0.021), but valve type was not independently associated with long-term prognosis after adjustment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: